网站大量收购独家精品文档,联系QQ:2885784924

Prevention and treatment of metformin on insulin resistance in the role of.doc

Prevention and treatment of metformin on insulin resistance in the role of.doc

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Prevention and treatment of metformin on insulin resistance in the role of

 PAGE \* MERGEFORMAT 4 Prevention and treatment of metformin on insulin resistance in the role of Diabetes mellitus (DM) is a group by a number of genetic and environmental factors caused by the combined effects of chronic, life-long non-communicable diseases. China is currently in the rise period DM, if not effectively contained, it is estimated in 2015 in China may have 60 million DM patients [1]. At present the view that insulin resistance (IR) and β-cell dysfunction in type 2 diabetes mellitus (T2DM) in the main pathogenesis [2]. IR associated with high insulin (INS) hyperlipidemia, glucose in the normal range during the best time to diabetes prevention and control, early behavioral intervention and drug intervention not only reduced the incidence of T2DM, but also to slow or correct the IR due to metabolic syndrome, prevention and treatment of DM during this period of great significance. T2DM, lipid metabolism disorders, hypertension, atherosclerosis (AS), coronary heart disease, visceral obesity has been known as the “metabolic syndrome”, which is one of the common causes of IR. Now that, in the early course of diabetes, no high blood sugar, most of the patients with IR already exists, and hyperlipidemia associated with high-INS to further develop, leading to pancreatic β-cell compensatory mechanism for a gradual decline, blood glucose increased, eventually occur T2DM. IR with high-INS hyperinsulinemia, predicting a single place an effective predictor of T2DM [3]. Metformin (MT) through weight loss, strengthening the role of the INS, inhibit glycogen production and reduce blood fat and reduce the IR. A weight loss Studies have shown that [4], MT in the treatment of polycystic ovary disease, even without dieting or not to increase the activity levels of the circumstances, it maid patients received weight loss. Confirmed by further studies, in 22 cases suffering from obesity, but no DM women and men with MT medication for 24 weeks,

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档